Results 171 to 180 of about 48,625 (267)

Treatment options for postmenopausal osteoporosis

open access: yes, 2012
Garry M WalshDivision of Applied Medicine, School of Medicine and Dentistry, Institute of Medical Sciences, University of Aberdeen, United KingdomTo serve our readership better, future editions of Therapeutics and Clinical Risk Management will once again
Walsh GM
core  

Comparing Teriparatide and Bisphosphonates for Postmenopausal Osteoporosis: A Systematic Review and Meta-Analysis of RCTs. [PDF]

open access: yesHealth Sci Rep
Uddin MZ   +11 more
europepmc   +1 more source

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis. [PDF]

open access: yesArthritis Rheumatol
Adami G   +10 more
europepmc   +1 more source

The role of genomic Copy Number Variation (CNV) in osteoporosis

open access: yes, 2012
Copy number variation (CNV) is a relatively novel source of genetic variation, involving the duplication or deletion of segments of genomic DNA (gDNA) sequence, thereby changing the original number of DNA copies.
Connolly, Kate
core  

The association between glutathione reductase and postmenopausal osteoporosis: a retrospective study. [PDF]

open access: yesFront Endocrinol (Lausanne)
Wang J   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy